Below are the financial statements of Genscript Biotech, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
All figures in millions of USD | 2024 | 2023 |
---|---|---|
Non-current assets | — | — |
Property, plant and equipment | 518a | 608.11a |
Advance payments for property, plant and equipment, net | 7.22a | 22.22a |
Investment properties | 4.85a | 5.44a |
Right-of-use assets | 77.62a | 120.62a |
Goodwill | 1.34a | 1.36a |
Other intangible assets | 13.04a | 18.65a |
Investments in associates | 3,667.73a | 15.29a |
Financial assets at fair value through profit or loss | 88.64a | 31.87a |
Deferred tax assets | 27.74a | 16.51a |
Time deposits | 33.39a | 38.25a |
Other non-current assets | 3.74a | 155.89a |
Total non-current assets | 4,443.29a | 1,034.19a |
Current assets | — | — |
Inventories | 31.1a | 53.35a |
Contract costs | 19.35a | 17.88a |
Trade and bills receivables | 116.29a | 217.44a |
Prepayments, other receivables and other assets | 29.14a | 103.32a |
Financial assets at fair value through profit or loss | 224.87a | 105.65a |
Restricted cash | 17.92a | 33.07a |
Time deposits | 264.32a | 376a |
Cash and cash equivalents | 131.99a | 1,446.4a |
Total current assets | 834.98a | 2,353.11a |
Current liabilities | — | — |
Trade and bills payables | 29.84a | 39.96a |
Other payables and accruals | 125.53a | 273.41a |
Interest-bearing loans and other borrowings | 88.75a | 57.01a |
Lease liabilities | 7.52a | 8.87a |
Tax payable | 9.39a | 18.13a |
Contract liabilities | 46.21a | 97.44a |
Financial liabilities at fair value through profit or loss | 0.11a | 0a |
Total current liabilities | 307.34a | 494.81a |
Net current assets | 527.64a | 1,858.3a |
Total assets less current liabilities | 4,970.93a | 2,892.49a |
Non-current liabilities | — | — |
Interest-bearing loans and other borrowings | 17.31a | 287.21a |
Lease liabilities | 56.99a | 63.91a |
Contract liabilities | 0a | 47.96a |
Deferred tax liabilities | 5.84a | 5.62a |
Financial liabilities at fair value through profit or loss | 473.73a | 350.15a |
Financial liabilities measured at amortised cost | 79.44a | 75.36a |
Other non-current liabilities | 14.26a | 17.93a |
Total non-current liabilities | 647.57a | 848.14a |
Net assets | 4,323.36a | 2,044.35a |
Equity | — | — |
Share capital | 2.14a | 2.12a |
Treasury shares | -6.09a | -9.45a |
Reserves | 4,325.12a | 1,398.4a |
Equity attributable to owners of the parent | 4,321.17a | 1,391.08a |
Non-controlling interests | 2.19a | 653.28a |
Total equity | 4,323.36a | 2,044.35a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genscript Biotech’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.